Please login to the form below
schools
This page shows the latest schools news and features for those working in and with pharma, biotech and healthcare.
PM announces plans to lift England’s COVID-19 restrictions
likely to continue rising, including in primary schools.” but that according to the government’s scientific advisors “it is likely that the Omicron wave has now peaked nationally”. ... compulsory in secondary school settings.
Latest news
-
FDA acting commissioner Janet Woodcock requests independent review of Aduhelm approval
Since Aduhelm's approval, three members of that panel have resigned, including Aaron Kesselheim, a professor of medicine at Harvard Medical School, who said the authorisation “was probably the worst drug
-
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
Since the approval, three members of that panel have resigned, including Aaron Kesselheim, a professor of medicine at Harvard Medical School, who said the authorisation “was probably the worst drug approval
-
Nature's way
Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School.
-
Roche's gantenerumab improves biomarkers in inherited form of Alzheimer’s disease
At the time, despite the disappointing results, analysis of gantenerumab continued in the DIAN-TU-001 trial, led by researchers from the Washington University School of Medicine.
-
Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease
As a result of the FDA approval of Aduhelm, three members of the committee have resigned, including Aaron Kesselheim – a professor of medicine at Harvard Medical School – who said the authorisation
More from news
Approximately 2 fully matching, plus 626 partially matching documents found.
Latest Intelligence
-
Straight outta lockdown – what’s next for flexible working?
deadlines with additional responsibilities, while full-time colleagues often feel burdened by additional last-minute deadlines that land after their colleagues have gone on the school run.
-
The future of work has been just around the corner for some time...
we provided 150 laptops to schools. Our well-established Dynamic Flexible Working policy allowed our people to transition to permanent homeworking immediately,.
-
Rare diseases: why they can be so difficult to identify
The patient’s HCPs may not have studied such disorders extensively during their medical training – or perhaps it was called something else when they were in medical school. ... The phrase, ‘When you hear hoofbeats, think horses, not zebras’, was
-
Why female mentorship is so powerful in pharma
They hear about other women’s experiences moving across the world for a tour of duty, taking stretch assignments, going back to school or planning maternity leave.
-
The promise of precision medicine
A significant effort will be required from health industry bodies, governments and medical schools to train workers so that they can perform the tasks that will be needed to fully exploit
More from intelligence
Approximately 0 fully matching, plus 89 partially matching documents found.
Latest appointments
-
Merck’s CEO Kenneth Frazier to retire after ten years in the role
from Columbia Business School and more.
-
Ashfield appoints new global head of quality and compliance
She also attended Rutgers University School of Law, and is a member of both the Pennsylvania and New Jersey Bar Associations and the Healthcare Compliance Association.
-
Porterhouse announces members of medical advisory group
She graduated from St Bartholomew’s and the London School of Medicine and Dentistry in 2001, working as a pathologist in the NHS until 2015.
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors
Horning received her MD from University of Iowa School of Medicine, and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University.
-
Health comms agency emotive hires new cell and gene therapy leader
She completed her post-doctoral training at Harvard Medical School and has spent over eight years working across a broad variety of research, regulatory, quality assurance and medical writing roles at
More from appointments
Approximately 0 fully matching, plus 43 partially matching documents found.
Latest from PMHub
-
Day in the life of an emotive Art Director
I would say my high school art teacher. I’ve made art my career and she wasn’t the last person to encourage me to do so. .
-
Three amazing women at emotive talk about what they love about medical communications
Dr Silvana Bardelli, Senior Medical Writer, has a PhD in human molecular genetics and completed her post-doctoral research at Harvard Medical School.
-
Genetic Digital
Clinics &medical practices. Doctors, consultants &surgeons. University medical schools.
-
Another Landmark Lucid Workiversary
My fascination with science started at school – I have always read a lot about the sciences and enjoy the journey of discovery.
-
Numbers, navigation, and narratives: digital storytelling in medical communications
Since the 1980s, American medical schools and hospitals have promoted so‑called narrative medicine in healthcare curricula to facilitate reflection and reduce the distance between technical understanding of the disease and
Genetic Digital
More from PMHub
Approximately 2 fully matching, plus 114 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- GSK appoint Tony Wood as chief scientific officer
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- SMC approves Parkinson’s disease treatment Ongentys
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- Home or away: where next for pharmaceutical symposia?
- PM announces plans to lift England’s COVID-19 restrictions
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- SMC approves Parkinson’s disease treatment Ongentys
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
